Arbutus Biopharma Corporation (ABUS)
NASDAQ · Healthcare
Arbutus Biopharma Corporation Net Income 2011–2025
Arbutus Biopharma Corporation annual/quarterly net income history and growth rate from 2011 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Arbutus Biopharma Corporation net income for the quarter ending March 31, 2026 was 169.7 M, a 791.90% decrease year-over-year.
- Arbutus Biopharma Corporation net income for the twelve months ending March 31, 2026 was 139.9 M, a 280.60% decrease year-over-year.
- Arbutus Biopharma Corporation annual net income for 2025 was -33.5 M, a 52.09% decrease from 2024.
- Arbutus Biopharma Corporation annual net income for 2024 was -69.9 M, a 4.02% decrease from 2023.
- Arbutus Biopharma Corporation annual net income for 2023 was -72.8 M, a 4.89% increase from 2022.
- Arbutus Biopharma Corporation annual net income for 2022 was -69.5 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Arbutus Biopharma Corporation Net Income — FAQ
Arbutus Biopharma Corporation (ABUS) net income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Arbutus Biopharma Corporation's net income?
Arbutus Biopharma Corporation (ABUS) reported net income of -$34M for fiscal 2025.
Where can I see ABUS's net income history?
The chart and table above show Arbutus Biopharma Corporation's net income by year and by quarter, including the growth rate.